Skip to main

Philippe Genereux

Philippe Généreux, MD is the medical director of the Structural Heart Program at Morristown Medical Center and has served as the primary or co-investigator on more than 20 clinical trials and has published more than 300 articles in peer-reviewed journals. He is currently the Principal Investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. For the last three years, Dr. Généreux has been named one of the world’s most highly cited researchers by the Clarivate™ Web of Science™ Group.